nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—Dactinomycin—sarcoma	0.119	0.136	CbGbCtD
Apixaban—ABCG2—Mitoxantrone—sarcoma	0.106	0.122	CbGbCtD
Apixaban—ABCG2—Vincristine—sarcoma	0.0732	0.0838	CbGbCtD
Apixaban—ABCG2—Etoposide—sarcoma	0.0671	0.0768	CbGbCtD
Apixaban—CYP1A2—Dacarbazine—sarcoma	0.0566	0.0647	CbGbCtD
Apixaban—CYP3A4—Thiotepa—sarcoma	0.0535	0.0612	CbGbCtD
Apixaban—ABCG2—Doxorubicin—sarcoma	0.0458	0.0524	CbGbCtD
Apixaban—ABCB1—Dactinomycin—sarcoma	0.0429	0.049	CbGbCtD
Apixaban—CYP3A5—Vincristine—sarcoma	0.0406	0.0464	CbGbCtD
Apixaban—ABCB1—Mitoxantrone—sarcoma	0.0384	0.0439	CbGbCtD
Apixaban—CYP3A5—Etoposide—sarcoma	0.0372	0.0425	CbGbCtD
Apixaban—CYP2C8—Etoposide—sarcoma	0.0358	0.0409	CbGbCtD
Apixaban—CYP1A2—Etoposide—sarcoma	0.0277	0.0317	CbGbCtD
Apixaban—ABCB1—Vincristine—sarcoma	0.0264	0.0302	CbGbCtD
Apixaban—ABCB1—Etoposide—sarcoma	0.0242	0.0277	CbGbCtD
Apixaban—CYP3A4—Mitoxantrone—sarcoma	0.023	0.0263	CbGbCtD
Apixaban—ABCB1—Doxorubicin—sarcoma	0.0165	0.0189	CbGbCtD
Apixaban—CYP3A4—Vincristine—sarcoma	0.0158	0.0181	CbGbCtD
Apixaban—CYP3A4—Etoposide—sarcoma	0.0145	0.0166	CbGbCtD
Apixaban—CYP3A4—Doxorubicin—sarcoma	0.00989	0.0113	CbGbCtD
Apixaban—Haemorrhage intracranial—Mitoxantrone—sarcoma	0.00287	0.0277	CcSEcCtD
Apixaban—Cerebral haemorrhage—Thiotepa—sarcoma	0.00246	0.0238	CcSEcCtD
Apixaban—F10—mammary gland—sarcoma	0.00235	0.106	CbGeAlD
Apixaban—Transaminases increased—Thiotepa—sarcoma	0.00224	0.0217	CcSEcCtD
Apixaban—Cerebral haemorrhage—Vincristine—sarcoma	0.00218	0.0211	CcSEcCtD
Apixaban—Vaginal haemorrhage—Thiotepa—sarcoma	0.00184	0.0178	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Thiotepa—sarcoma	0.00166	0.016	CcSEcCtD
Apixaban—Menorrhagia—Vincristine—sarcoma	0.00163	0.0158	CcSEcCtD
Apixaban—Menorrhagia—Mitoxantrone—sarcoma	0.00159	0.0154	CcSEcCtD
Apixaban—Blood bilirubin increased—Thiotepa—sarcoma	0.00144	0.0139	CcSEcCtD
Apixaban—F10—hematopoietic system—sarcoma	0.00143	0.0643	CbGeAlD
Apixaban—Petechiae—Mitoxantrone—sarcoma	0.00143	0.0138	CcSEcCtD
Apixaban—Gamma-glutamyltransferase increased—Mitoxantrone—sarcoma	0.00143	0.0138	CcSEcCtD
Apixaban—Haematochezia—Epirubicin—sarcoma	0.00136	0.0132	CcSEcCtD
Apixaban—Drug hypersensitivity—Epirubicin—sarcoma	0.00136	0.0132	CcSEcCtD
Apixaban—Contusion—Mitoxantrone—sarcoma	0.00135	0.013	CcSEcCtD
Apixaban—Drug hypersensitivity—Doxorubicin—sarcoma	0.00126	0.0122	CcSEcCtD
Apixaban—Haematochezia—Doxorubicin—sarcoma	0.00126	0.0122	CcSEcCtD
Apixaban—Blood bilirubin increased—Mitoxantrone—sarcoma	0.00124	0.012	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Thiotepa—sarcoma	0.00114	0.011	CcSEcCtD
Apixaban—F10—cardiac atrium—sarcoma	0.00109	0.0488	CbGeAlD
Apixaban—Ecchymosis—Mitoxantrone—sarcoma	0.00106	0.0103	CcSEcCtD
Apixaban—CYP2J2—skin of body—sarcoma	0.00102	0.0458	CbGeAlD
Apixaban—Gingival bleeding—Epirubicin—sarcoma	0.000966	0.00935	CcSEcCtD
Apixaban—F10—tendon—sarcoma	0.000949	0.0426	CbGeAlD
Apixaban—Liver function test abnormal—Dactinomycin—sarcoma	0.000906	0.00877	CcSEcCtD
Apixaban—Transaminases increased—Epirubicin—sarcoma	0.000901	0.00872	CcSEcCtD
Apixaban—Gingival bleeding—Doxorubicin—sarcoma	0.000894	0.00865	CcSEcCtD
Apixaban—CYP2J2—cardiac atrium—sarcoma	0.000893	0.04	CbGeAlD
Apixaban—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.00089	0.00861	CcSEcCtD
Apixaban—CYP2J2—uterus—sarcoma	0.000888	0.0398	CbGeAlD
Apixaban—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.000883	0.00855	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Thiotepa—sarcoma	0.000872	0.00844	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.000854	0.00826	CcSEcCtD
Apixaban—Transaminases increased—Doxorubicin—sarcoma	0.000834	0.00807	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Etoposide—sarcoma	0.000816	0.0079	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Vincristine—sarcoma	0.000789	0.00764	CcSEcCtD
Apixaban—Haematemesis—Epirubicin—sarcoma	0.000789	0.00764	CcSEcCtD
Apixaban—F10—testis—sarcoma	0.000786	0.0353	CbGeAlD
Apixaban—CYP2J2—tendon—sarcoma	0.000778	0.0349	CbGeAlD
Apixaban—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.000769	0.00744	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.000753	0.00729	CcSEcCtD
Apixaban—CYP2C8—mammary gland—sarcoma	0.000753	0.0337	CbGeAlD
Apixaban—F10—liver—sarcoma	0.000743	0.0333	CbGeAlD
Apixaban—Vaginal haemorrhage—Epirubicin—sarcoma	0.000741	0.00717	CcSEcCtD
Apixaban—Haemoptysis—Epirubicin—sarcoma	0.000741	0.00717	CcSEcCtD
Apixaban—Haematemesis—Doxorubicin—sarcoma	0.00073	0.00707	CcSEcCtD
Apixaban—Haematuria—Thiotepa—sarcoma	0.000726	0.00703	CcSEcCtD
Apixaban—Hepatobiliary disease—Thiotepa—sarcoma	0.00072	0.00697	CcSEcCtD
Apixaban—Epistaxis—Thiotepa—sarcoma	0.000718	0.00695	CcSEcCtD
Apixaban—Haemoglobin—Thiotepa—sarcoma	0.000687	0.00665	CcSEcCtD
Apixaban—Vaginal haemorrhage—Doxorubicin—sarcoma	0.000685	0.00663	CcSEcCtD
Apixaban—Haemoptysis—Doxorubicin—sarcoma	0.000685	0.00663	CcSEcCtD
Apixaban—Haemorrhage—Thiotepa—sarcoma	0.000684	0.00662	CcSEcCtD
Apixaban—Urinary tract disorder—Thiotepa—sarcoma	0.000675	0.00654	CcSEcCtD
Apixaban—Connective tissue disorder—Thiotepa—sarcoma	0.000672	0.0065	CcSEcCtD
Apixaban—Urethral disorder—Thiotepa—sarcoma	0.00067	0.00649	CcSEcCtD
Apixaban—CYP2C9—mammary gland—sarcoma	0.000668	0.03	CbGeAlD
Apixaban—Petechiae—Epirubicin—sarcoma	0.000666	0.00645	CcSEcCtD
Apixaban—CYP2J2—testis—sarcoma	0.000644	0.0289	CbGeAlD
Apixaban—Eye disorder—Thiotepa—sarcoma	0.000639	0.00618	CcSEcCtD
Apixaban—Haematuria—Mitoxantrone—sarcoma	0.000627	0.00607	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Etoposide—sarcoma	0.000626	0.00606	CcSEcCtD
Apixaban—Angiopathy—Thiotepa—sarcoma	0.00062	0.006	CcSEcCtD
Apixaban—Immune system disorder—Thiotepa—sarcoma	0.000618	0.00598	CcSEcCtD
Apixaban—Petechiae—Doxorubicin—sarcoma	0.000617	0.00597	CcSEcCtD
Apixaban—Mediastinal disorder—Thiotepa—sarcoma	0.000616	0.00596	CcSEcCtD
Apixaban—CYP2J2—liver—sarcoma	0.000609	0.0273	CbGeAlD
Apixaban—Rectal haemorrhage—Epirubicin—sarcoma	0.000607	0.00587	CcSEcCtD
Apixaban—Urinary tract disorder—Vincristine—sarcoma	0.000599	0.0058	CcSEcCtD
Apixaban—Connective tissue disorder—Vincristine—sarcoma	0.000596	0.00577	CcSEcCtD
Apixaban—Urethral disorder—Vincristine—sarcoma	0.000594	0.00575	CcSEcCtD
Apixaban—Haemoglobin—Mitoxantrone—sarcoma	0.000593	0.00574	CcSEcCtD
Apixaban—Haemorrhage—Mitoxantrone—sarcoma	0.00059	0.00572	CcSEcCtD
Apixaban—Blood bilirubin increased—Epirubicin—sarcoma	0.00058	0.00561	CcSEcCtD
Apixaban—F10—lymph node—sarcoma	0.00057	0.0256	CbGeAlD
Apixaban—Rectal haemorrhage—Doxorubicin—sarcoma	0.000562	0.00544	CcSEcCtD
Apixaban—Anaemia—Thiotepa—sarcoma	0.00055	0.00532	CcSEcCtD
Apixaban—Angiopathy—Vincristine—sarcoma	0.00055	0.00532	CcSEcCtD
Apixaban—Mediastinal disorder—Vincristine—sarcoma	0.000546	0.00529	CcSEcCtD
Apixaban—Anaemia—Dactinomycin—sarcoma	0.000546	0.00528	CcSEcCtD
Apixaban—Blood bilirubin increased—Doxorubicin—sarcoma	0.000536	0.00519	CcSEcCtD
Apixaban—Melaena—Epirubicin—sarcoma	0.000536	0.00518	CcSEcCtD
Apixaban—CYP2C19—hematopoietic system—sarcoma	0.000525	0.0236	CbGeAlD
Apixaban—ABCG2—myometrium—sarcoma	0.000519	0.0233	CbGeAlD
Apixaban—Hepatobiliary disease—Etoposide—sarcoma	0.000517	0.00501	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000503	0.00487	CcSEcCtD
Apixaban—Ecchymosis—Epirubicin—sarcoma	0.000496	0.0048	CcSEcCtD
Apixaban—Melaena—Doxorubicin—sarcoma	0.000496	0.0048	CcSEcCtD
Apixaban—Anaemia—Vincristine—sarcoma	0.000488	0.00472	CcSEcCtD
Apixaban—Urinary tract disorder—Etoposide—sarcoma	0.000485	0.00469	CcSEcCtD
Apixaban—Urethral disorder—Etoposide—sarcoma	0.000481	0.00466	CcSEcCtD
Apixaban—Nervous system disorder—Thiotepa—sarcoma	0.000476	0.00461	CcSEcCtD
Apixaban—Thrombocytopenia—Thiotepa—sarcoma	0.000476	0.0046	CcSEcCtD
Apixaban—Anaemia—Mitoxantrone—sarcoma	0.000475	0.0046	CcSEcCtD
Apixaban—Thrombocytopenia—Dactinomycin—sarcoma	0.000472	0.00457	CcSEcCtD
Apixaban—Skin disorder—Thiotepa—sarcoma	0.000472	0.00457	CcSEcCtD
Apixaban—ABCG2—seminal vesicle—sarcoma	0.000469	0.021	CbGeAlD
Apixaban—Eye disorder—Etoposide—sarcoma	0.000459	0.00444	CcSEcCtD
Apixaban—Ecchymosis—Doxorubicin—sarcoma	0.000459	0.00444	CcSEcCtD
Apixaban—CYP2C8—hematopoietic system—sarcoma	0.000459	0.0206	CbGeAlD
Apixaban—Diabetes mellitus—Epirubicin—sarcoma	0.000458	0.00443	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.000458	0.00443	CcSEcCtD
Apixaban—Angiopathy—Etoposide—sarcoma	0.000446	0.00431	CcSEcCtD
Apixaban—Immune system disorder—Etoposide—sarcoma	0.000444	0.00429	CcSEcCtD
Apixaban—Mediastinal disorder—Etoposide—sarcoma	0.000443	0.00428	CcSEcCtD
Apixaban—Anaphylactic shock—Vincristine—sarcoma	0.000431	0.00417	CcSEcCtD
Apixaban—CYP1A2—hematopoietic system—sarcoma	0.000429	0.0192	CbGeAlD
Apixaban—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.000423	0.0041	CcSEcCtD
Apixaban—Diabetes mellitus—Doxorubicin—sarcoma	0.000423	0.0041	CcSEcCtD
Apixaban—Nervous system disorder—Vincristine—sarcoma	0.000422	0.00409	CcSEcCtD
Apixaban—Thrombocytopenia—Vincristine—sarcoma	0.000422	0.00408	CcSEcCtD
Apixaban—Anaphylactic shock—Mitoxantrone—sarcoma	0.00042	0.00406	CcSEcCtD
Apixaban—Gastrointestinal disorder—Thiotepa—sarcoma	0.000419	0.00406	CcSEcCtD
Apixaban—CYP3A5—hematopoietic system—sarcoma	0.000414	0.0186	CbGeAlD
Apixaban—Shock—Mitoxantrone—sarcoma	0.000413	0.00399	CcSEcCtD
Apixaban—Thrombocytopenia—Mitoxantrone—sarcoma	0.000411	0.00398	CcSEcCtD
Apixaban—Skin disorder—Mitoxantrone—sarcoma	0.000407	0.00394	CcSEcCtD
Apixaban—CYP2C9—hematopoietic system—sarcoma	0.000407	0.0183	CbGeAlD
Apixaban—Hypotension—Vincristine—sarcoma	0.000403	0.0039	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000398	0.00385	CcSEcCtD
Apixaban—Anaemia—Etoposide—sarcoma	0.000395	0.00382	CcSEcCtD
Apixaban—Hypotension—Mitoxantrone—sarcoma	0.000392	0.00379	CcSEcCtD
Apixaban—Loss of consciousness—Etoposide—sarcoma	0.000376	0.00364	CcSEcCtD
Apixaban—Gastrointestinal disorder—Vincristine—sarcoma	0.000372	0.0036	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000368	0.00356	CcSEcCtD
Apixaban—Liver function test abnormal—Epirubicin—sarcoma	0.000367	0.00356	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000362	0.0035	CcSEcCtD
Apixaban—Breast disorder—Epirubicin—sarcoma	0.00036	0.00348	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000358	0.00347	CcSEcCtD
Apixaban—Hypersensitivity—Thiotepa—sarcoma	0.000358	0.00346	CcSEcCtD
Apixaban—Hypersensitivity—Dactinomycin—sarcoma	0.000355	0.00344	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000351	0.0034	CcSEcCtD
Apixaban—Anaphylactic shock—Etoposide—sarcoma	0.000349	0.00338	CcSEcCtD
Apixaban—Thrombocytopenia—Etoposide—sarcoma	0.000342	0.00331	CcSEcCtD
Apixaban—Liver function test abnormal—Doxorubicin—sarcoma	0.00034	0.00329	CcSEcCtD
Apixaban—Skin disorder—Etoposide—sarcoma	0.000339	0.00328	CcSEcCtD
Apixaban—ABCG2—uterus—sarcoma	0.000337	0.0151	CbGeAlD
Apixaban—Breast disorder—Doxorubicin—sarcoma	0.000333	0.00322	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000332	0.00321	CcSEcCtD
Apixaban—Hypotension—Etoposide—sarcoma	0.000326	0.00316	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000325	0.00314	CcSEcCtD
Apixaban—Dizziness—Thiotepa—sarcoma	0.000321	0.00311	CcSEcCtD
Apixaban—Hypersensitivity—Vincristine—sarcoma	0.000317	0.00307	CcSEcCtD
Apixaban—CYP3A4—hematopoietic system—sarcoma	0.000311	0.0139	CbGeAlD
Apixaban—Hypersensitivity—Mitoxantrone—sarcoma	0.000309	0.00299	CcSEcCtD
Apixaban—Rash—Thiotepa—sarcoma	0.000306	0.00296	CcSEcCtD
Apixaban—Dermatitis—Thiotepa—sarcoma	0.000306	0.00296	CcSEcCtD
Apixaban—Rash—Dactinomycin—sarcoma	0.000304	0.00294	CcSEcCtD
Apixaban—Gastrointestinal disorder—Etoposide—sarcoma	0.000301	0.00292	CcSEcCtD
Apixaban—Haematuria—Epirubicin—sarcoma	0.000292	0.00283	CcSEcCtD
Apixaban—Hepatobiliary disease—Epirubicin—sarcoma	0.00029	0.00281	CcSEcCtD
Apixaban—Epistaxis—Epirubicin—sarcoma	0.000289	0.0028	CcSEcCtD
Apixaban—Nausea—Thiotepa—sarcoma	0.000289	0.00279	CcSEcCtD
Apixaban—Nausea—Dactinomycin—sarcoma	0.000286	0.00277	CcSEcCtD
Apixaban—ABCG2—bone marrow—sarcoma	0.000286	0.0128	CbGeAlD
Apixaban—Dizziness—Vincristine—sarcoma	0.000285	0.00276	CcSEcCtD
Apixaban—Haemoglobin—Epirubicin—sarcoma	0.000277	0.00268	CcSEcCtD
Apixaban—Haemorrhage—Epirubicin—sarcoma	0.000275	0.00266	CcSEcCtD
Apixaban—CYP2C19—liver—sarcoma	0.000272	0.0122	CbGeAlD
Apixaban—Urinary tract disorder—Epirubicin—sarcoma	0.000272	0.00263	CcSEcCtD
Apixaban—Rash—Vincristine—sarcoma	0.000272	0.00263	CcSEcCtD
Apixaban—Dermatitis—Vincristine—sarcoma	0.000271	0.00263	CcSEcCtD
Apixaban—Haematuria—Doxorubicin—sarcoma	0.000271	0.00262	CcSEcCtD
Apixaban—Connective tissue disorder—Epirubicin—sarcoma	0.000271	0.00262	CcSEcCtD
Apixaban—Urethral disorder—Epirubicin—sarcoma	0.00027	0.00261	CcSEcCtD
Apixaban—Hepatobiliary disease—Doxorubicin—sarcoma	0.000268	0.0026	CcSEcCtD
Apixaban—Epistaxis—Doxorubicin—sarcoma	0.000268	0.00259	CcSEcCtD
Apixaban—Rash—Mitoxantrone—sarcoma	0.000265	0.00256	CcSEcCtD
Apixaban—Dermatitis—Mitoxantrone—sarcoma	0.000264	0.00256	CcSEcCtD
Apixaban—Eye disorder—Epirubicin—sarcoma	0.000257	0.00249	CcSEcCtD
Apixaban—Hypersensitivity—Etoposide—sarcoma	0.000257	0.00249	CcSEcCtD
Apixaban—Haemoglobin—Doxorubicin—sarcoma	0.000256	0.00248	CcSEcCtD
Apixaban—ABCB1—myometrium—sarcoma	0.000256	0.0115	CbGeAlD
Apixaban—Nausea—Vincristine—sarcoma	0.000256	0.00248	CcSEcCtD
Apixaban—Haemorrhage—Doxorubicin—sarcoma	0.000255	0.00247	CcSEcCtD
Apixaban—Urinary tract disorder—Doxorubicin—sarcoma	0.000252	0.00244	CcSEcCtD
Apixaban—CYP2C8—testis—sarcoma	0.000251	0.0113	CbGeAlD
Apixaban—Connective tissue disorder—Doxorubicin—sarcoma	0.00025	0.00242	CcSEcCtD
Apixaban—Angiopathy—Epirubicin—sarcoma	0.00025	0.00242	CcSEcCtD
Apixaban—Urethral disorder—Doxorubicin—sarcoma	0.00025	0.00242	CcSEcCtD
Apixaban—Nausea—Mitoxantrone—sarcoma	0.000249	0.00241	CcSEcCtD
Apixaban—Immune system disorder—Epirubicin—sarcoma	0.000249	0.00241	CcSEcCtD
Apixaban—Mediastinal disorder—Epirubicin—sarcoma	0.000248	0.0024	CcSEcCtD
Apixaban—ABCB1—embryo—sarcoma	0.000246	0.011	CbGeAlD
Apixaban—ABCG2—testis—sarcoma	0.000244	0.011	CbGeAlD
Apixaban—Eye disorder—Doxorubicin—sarcoma	0.000238	0.0023	CcSEcCtD
Apixaban—CYP2C8—liver—sarcoma	0.000238	0.0107	CbGeAlD
Apixaban—ABCB1—seminal vesicle—sarcoma	0.000231	0.0104	CbGeAlD
Apixaban—Angiopathy—Doxorubicin—sarcoma	0.000231	0.00224	CcSEcCtD
Apixaban—ABCG2—liver—sarcoma	0.000231	0.0104	CbGeAlD
Apixaban—Dizziness—Etoposide—sarcoma	0.000231	0.00223	CcSEcCtD
Apixaban—Immune system disorder—Doxorubicin—sarcoma	0.00023	0.00223	CcSEcCtD
Apixaban—Mediastinal disorder—Doxorubicin—sarcoma	0.00023	0.00222	CcSEcCtD
Apixaban—CYP1A2—liver—sarcoma	0.000222	0.00997	CbGeAlD
Apixaban—Anaemia—Epirubicin—sarcoma	0.000222	0.00214	CcSEcCtD
Apixaban—Rash—Etoposide—sarcoma	0.00022	0.00213	CcSEcCtD
Apixaban—ABCB1—hematopoietic system—sarcoma	0.00022	0.00986	CbGeAlD
Apixaban—Dermatitis—Etoposide—sarcoma	0.00022	0.00213	CcSEcCtD
Apixaban—Syncope—Epirubicin—sarcoma	0.000215	0.00208	CcSEcCtD
Apixaban—CYP3A5—liver—sarcoma	0.000214	0.00961	CbGeAlD
Apixaban—CYP2C9—liver—sarcoma	0.000211	0.00946	CbGeAlD
Apixaban—Loss of consciousness—Epirubicin—sarcoma	0.000211	0.00204	CcSEcCtD
Apixaban—Nausea—Etoposide—sarcoma	0.000207	0.00201	CcSEcCtD
Apixaban—Anaemia—Doxorubicin—sarcoma	0.000205	0.00198	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000203	0.00196	CcSEcCtD
Apixaban—Syncope—Doxorubicin—sarcoma	0.000199	0.00192	CcSEcCtD
Apixaban—Anaphylactic shock—Epirubicin—sarcoma	0.000196	0.00189	CcSEcCtD
Apixaban—Loss of consciousness—Doxorubicin—sarcoma	0.000195	0.00189	CcSEcCtD
Apixaban—Shock—Epirubicin—sarcoma	0.000192	0.00186	CcSEcCtD
Apixaban—Nervous system disorder—Epirubicin—sarcoma	0.000192	0.00186	CcSEcCtD
Apixaban—Thrombocytopenia—Epirubicin—sarcoma	0.000192	0.00185	CcSEcCtD
Apixaban—Skin disorder—Epirubicin—sarcoma	0.00019	0.00184	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000187	0.00181	CcSEcCtD
Apixaban—Hypotension—Epirubicin—sarcoma	0.000183	0.00177	CcSEcCtD
Apixaban—Anaphylactic shock—Doxorubicin—sarcoma	0.000181	0.00175	CcSEcCtD
Apixaban—Shock—Doxorubicin—sarcoma	0.000178	0.00172	CcSEcCtD
Apixaban—Nervous system disorder—Doxorubicin—sarcoma	0.000177	0.00172	CcSEcCtD
Apixaban—Thrombocytopenia—Doxorubicin—sarcoma	0.000177	0.00172	CcSEcCtD
Apixaban—ABCG2—lymph node—sarcoma	0.000177	0.00794	CbGeAlD
Apixaban—Skin disorder—Doxorubicin—sarcoma	0.000176	0.0017	CcSEcCtD
Apixaban—Hypotension—Doxorubicin—sarcoma	0.000169	0.00164	CcSEcCtD
Apixaban—Gastrointestinal disorder—Epirubicin—sarcoma	0.000169	0.00163	CcSEcCtD
Apixaban—ABCB1—uterus—sarcoma	0.000166	0.00745	CbGeAlD
Apixaban—CYP3A4—liver—sarcoma	0.000161	0.00721	CbGeAlD
Apixaban—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000156	0.00151	CcSEcCtD
Apixaban—ABCB1—lymphoid tissue—sarcoma	0.000155	0.00694	CbGeAlD
Apixaban—Hypersensitivity—Epirubicin—sarcoma	0.000144	0.00139	CcSEcCtD
Apixaban—ABCB1—bone marrow—sarcoma	0.000141	0.00632	CbGeAlD
Apixaban—Hypersensitivity—Doxorubicin—sarcoma	0.000133	0.00129	CcSEcCtD
Apixaban—Dizziness—Epirubicin—sarcoma	0.000129	0.00125	CcSEcCtD
Apixaban—Rash—Epirubicin—sarcoma	0.000123	0.00119	CcSEcCtD
Apixaban—Dermatitis—Epirubicin—sarcoma	0.000123	0.00119	CcSEcCtD
Apixaban—ABCB1—testis—sarcoma	0.00012	0.0054	CbGeAlD
Apixaban—Dizziness—Doxorubicin—sarcoma	0.00012	0.00116	CcSEcCtD
Apixaban—Nausea—Epirubicin—sarcoma	0.000116	0.00112	CcSEcCtD
Apixaban—Rash—Doxorubicin—sarcoma	0.000114	0.0011	CcSEcCtD
Apixaban—Dermatitis—Doxorubicin—sarcoma	0.000114	0.0011	CcSEcCtD
Apixaban—ABCB1—liver—sarcoma	0.000114	0.00511	CbGeAlD
Apixaban—Nausea—Doxorubicin—sarcoma	0.000108	0.00104	CcSEcCtD
Apixaban—ABCB1—lymph node—sarcoma	8.73e-05	0.00392	CbGeAlD
